Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Abivax (ABVX)

Abivax SA
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ABVX
DateTimeSourceHeadlineSymbolCompany
21/02/202507:30GlobeNewswire Inc.Abivax to Host Key Opinion Leader (KOL) Webcast on March 17, 2025NASDAQ:ABVXAbivax SA
28/01/202507:30GlobeNewswire Inc.Abivax Publishes 2025 Financial CalendarNASDAQ:ABVXAbivax SA
23/01/202521:05GlobeNewswire Inc.Abivax Announces Presentation of Seven Abstracts for Obefazimod in Ulcerative Colitis at 2025 European Crohn’s and Colitis Organization 20th Annual CongressNASDAQ:ABVXAbivax SA
10/01/202514:04Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ABVXAbivax SA
09/01/202516:35GlobeNewswire Inc.Abivax Achieves Key Milestone in Phase 3 ABTECT Trial EnrollmentNASDAQ:ABVXAbivax SA
23/12/202422:14Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ABVXAbivax SA
23/12/202421:05GlobeNewswire Inc.Abivax Announces a Change to the Composition of its Board of DirectorsNASDAQ:ABVXAbivax SA
27/11/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ABVXAbivax SA
19/11/202421:43Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ABVXAbivax SA
19/11/202421:30GlobeNewswire Inc.Abivax Establishes an At-the-Market (ATM) Program on NasdaqNASDAQ:ABVXAbivax SA
19/11/202421:02Edgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersNASDAQ:ABVXAbivax SA
14/11/202421:01GlobeNewswire Inc.Abivax presents third quarter 2024 key financial informationNASDAQ:ABVXAbivax SA
14/11/202421:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ABVXAbivax SA
13/11/202421:01GlobeNewswire Inc.Abivax Announces Former Prometheus COO, Mark Stenhouse, Appointed as Board Observer & Advisor to AbivaxNASDAQ:ABVXAbivax SA
07/10/202420:01GlobeNewswire Inc.Abivax Congratulates Victor Ambros and Gary Ruvkun on Their Nobel Prize for the Discovery of microRNA and its Role in Post-Transcriptional Gene RegulationNASDAQ:ABVXAbivax SA
03/10/202420:18Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ABVXAbivax SA
03/10/202420:01GlobeNewswire Inc.Abivax Announces First Patient Enrolled in ENHANCE-CD, the Phase 2b Trial of Obefazimod in Crohn’s DiseaseNASDAQ:ABVXAbivax SA
03/10/202410:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ABVXAbivax SA
03/10/202406:31GlobeNewswire Inc.Abivax Reports Positive Interim Efficacy and Safety Analysis of Once-Daily 25mg Obefazimod in Moderate to Severe Ulcerative Colitis Patients After 2-Years of Open-Label MaintenanceNASDAQ:ABVXAbivax SA
26/09/202410:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ABVXAbivax SA
26/09/202406:30GlobeNewswire Inc.Abivax to Present Three Abstracts for Obefazimod in Ulcerative Colitis at the UEG Week 2024NASDAQ:ABVXAbivax SA
25/09/202420:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ABVXAbivax SA
25/09/202420:01GlobeNewswire Inc.Abivax Provides Update on Ulcerative Colitis (UC) Combination Therapy Program Strategy and Announces Early Preclinical Combination Data of Obefazimod and Etrasimod in Inflammatory Bowel Disease (IBD) Mouse ModelNASDAQ:ABVXAbivax SA
09/09/202420:27Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ABVXAbivax SA
09/09/202420:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ABVXAbivax SA
09/09/202420:01GlobeNewswire Inc.Abivax presents first-half 2024 financial resultsNASDAQ:ABVXAbivax SA
09/09/202410:09IH Market NewsU.S. Futures Rise Amid Inflation Report Anticipation; Oil Prices Climb on Hurricane Threat and Supply ConcernsNASDAQ:ABVXAbivax SA
06/08/202406:30GlobeNewswire Inc.Abivax Announces ABTECT Phase 3 Trial Achieves Key Enrollment MilestoneNASDAQ:ABVXAbivax SA
15/07/202420:00GlobeNewswire Inc.Abivax Provides Operational and Key Program UpdateNASDAQ:ABVXAbivax SA
04/06/202420:26Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ABVXAbivax SA
 Showing the most relevant articles for your search:NASDAQ:ABVX